Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Palmitate measurement |
Has measured component |
False |
Palmitic acid |
Inferred relationship |
Some |
|
Palmitate measurement |
Component |
True |
Palmitic acid |
Inferred relationship |
Some |
1 |
Product containing galactose and palmitic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Amniotic fluid palmitic acid measurement (procedure) |
Component |
False |
Palmitic acid |
Inferred relationship |
Some |
2 |
Ascorbyl palmitate |
Is a |
False |
Palmitic acid |
Inferred relationship |
Some |
|
Ascorbyl palmitate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Palmitic acid |
Inferred relationship |
Some |
|
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Carbon (11-C) palmitate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Palmitic acid |
Inferred relationship |
Some |
|
Product containing galactose and palmitic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Galactose and palmitic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Product containing only galactose and palmitic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Palmitic acid |
Inferred relationship |
Some |
2 |
Amniotic fluid palmitic acid measurement (procedure) |
Component |
True |
Palmitic acid |
Inferred relationship |
Some |
1 |